Condition
Traumatic Wounds
Total Trials
6
Recruiting
3
Active
3
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
66.7%
-19.9% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting3
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07312513Not ApplicableCompleted
Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds
NCT07255937Not ApplicableCompleted
PMCF Study of Debridement Pad
NCT07617961Recruiting
THERAVEX Tissue Care Spray Plus for the Management of Cutaneous Wounds, Burns, and Chronic Ulcers
NCT02280733Recruiting
A Real-World Registry of Chronic Wounds and Ulcers
NCT04920253Not ApplicableRecruiting
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
NCT04826965Not ApplicableTerminated
VAC Bioburden Wound Care Assessment
Showing all 6 trials